Lam, Yu Ming Paul <br/><br/>
Switching virally suppressed, treatment-experienced patients to a raltegravir-containing regimen does not alter levels of HIV-1 DNA.  [electronic resource] 

 -  PloS one  2012 
 - e31990 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1932-6203 
<br/><br/><label>Standard No.: </label>10.1371/journal.pone.0031990  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antiviral Agents--pharmacology<br/>Cohort Studies<br/>DNA--metabolism<br/>DNA Primers--genetics<br/>DNA, Viral--genetics<br/>HIV Infections--drug therapy<br/>HIV-1--genetics<br/>Humans<br/>Leukocytes, Mononuclear--cytology<br/>Male<br/>Middle Aged<br/>Pyrrolidinones--pharmacology<br/>Raltegravir Potassium<br/>Real-Time Polymerase Chain Reaction--methods<br/>Terminal Repeat Sequences<br/>Viral Load